ReP USP - Resultado da busca

Artigo de periodico
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)
Dicker, Daniel; Nguyen, Grant; Abate, Degu; Abate, Kalkidan Hassen; Abay, Solomon M; Abbafati, Cristiana; Abbasi, Nooshin; Abbastabar, Hedayat; Abd-Allah, Foad; Abdela, Jemal; Furtado, João Marcello Fortes
Source: Lancet. Unidade: FMRP
Subjects: MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, CONDIÇÕES DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DICKER, Daniel et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, v. 392, n. 10159, p. 1684-1735, 2018Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(18)31891-9. Acesso em: 31 ago. 2024.
APA
Dicker, D., Nguyen, G., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., et al. (2018). Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392( 10159), 1684-1735. doi:10.1016/s0140-6736(18)31891-9
NLM
Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Furtado JMF. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet. 2018 ; 392( 10159): 1684-1735.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/s0140-6736(18)31891-9
Vancouver
Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Furtado JMF. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet. 2018 ; 392( 10159): 1684-1735.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/s0140-6736(18)31891-9
Artigo de periodico
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Goulart, Alessandra Carvalho; Santos, Itamar de Souza; Benseñor, Isabela M; Lotufo, Paulo Andrade; Furtado, João Marcello Fortes; Wang, Yuan-Pang
Source: Lancet. Unidades: FM, FMRP, HU
Subjects: MORTALIDADE, DOENÇAS TRANSMISSÍVEIS, CAUSA DA MORTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOULART, Alessandra Carvalho et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1151-1210, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32152-9. Acesso em: 31 ago. 2024.
APA
Goulart, A. C., Santos, I. de S., Benseñor, I. M., Lotufo, P. A., Furtado, J. M. F., & Wang, Y. -P. (2017). Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1151-1210. doi:10.1016/S0140-6736(17)32152-9
NLM
Goulart AC, Santos I de S, Benseñor IM, Lotufo PA, Furtado JMF, Wang Y-P. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1151-1210.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(17)32152-9
Vancouver
Goulart AC, Santos I de S, Benseñor IM, Lotufo PA, Furtado JMF, Wang Y-P. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1151-1210.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(17)32152-9
Artigo de periodico
Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Assunto: CARDIOLOGIA (CIRURGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, v. 371, n. 9627, p. 1839-1847, 2008Tradução . . Acesso em: 31 ago. 2024.
APA
Marin-Neto, J. A. (2008). Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet, 371( 9627), 1839-1847.
NLM
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 31 ]
Vancouver
Marin-Neto JA. Effects extended release metoprolol succinate in patients undergoing non cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 ; 371( 9627): 1839-1847.[citado 2024 ago. 31 ]
Artigo de periodico
Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, ANGIOTENSINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, v. 372, n. 9644, p. 1174-1183, 2008Tradução . . Acesso em: 31 ago. 2024.
APA
Marin-Neto, J. A. (2008). Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet, 372( 9644), 1174-1183.
NLM
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 31 ]
Vancouver
Marin-Neto JA. Effects of the angiotensin receptor blocker telmisartan on cardiovascular events in high-rish patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 ; 372( 9644): 1174-1183.[citado 2024 ago. 31 ]
Artigo de periodico
Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled (2008)
Marin-Neto, José Antônio
Source: Lancet. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, v. 372, n. 9638, p. 547-553, 2008Tradução . . Acesso em: 31 ago. 2024.
APA
Marin-Neto, J. A. (2008). Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet, 372( 9638), 547-553.
NLM
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 31 ]
Vancouver
Marin-Neto JA. Renal outcomes with telmisartan, ramipril, or both, in people at high varcular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled. Lancet. 2008 ; 372( 9638): 547-553.[citado 2024 ago. 31 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration